Alliance for Cancer Gene Therapy Summit 2021 features world renowned cancer researchers advancing so
James P. Allison, PhD, Carl H. June, MD and Siddhartha Mukherjee, MD Keynote April 29 Summit
Read morenews, journals and articles from all over the world.
James P. Allison, PhD, Carl H. June, MD and Siddhartha Mukherjee, MD Keynote April 29 Summit
Read moreGlioblastomas are the most common and most aggressive brain tumours. Their survival rate has barely increased over the last 50
Read moreIn an article published in the April 8 issue of Nature , the National Institutes of Health’s Somatic Cell Gene
Read moreA UCLA research team has shown that using a truncated form of the CD4 molecule as part of a gene therapy to combat HIV yielded superior and longer-lasting results in mouse models than previous similar therapies using the CD4 molecule.
Read moreToolkit easily incorporates into any laboratory science course
Read moreNagoya University researchers have identified a gene that plays a crucial role in regenerating neurons of African clawed frog tadpoles,
Read moreScientists at the University of Cambridge have shown in animal studies that gene therapy may help repair some of the
Read moreThe latest gene editing technology, prime editing, expands the “genetic toolbox” for more precisely creating disease models and correcting genetic
Read moreIn a new study published in the Cell Research , Chen-Yu Zhang’s group at Nanjing University reports “In vivo self-assembled
Read moreAmerican Association for Cancer Research honors distinguished USC Norris Comprehensive Cancer Center scientist
Read moreNovel DLD assay is capable of rapidly assessing host inflammatory response, allowing patients exhibiting a life-threatening hyper-aggressive immune response to be identified and treated expeditiously
Read morePrecision genome editing enables the precise modification of DNA in living cells, thus enabling a breadth of opportunities for plant
Read moreGlioma is a fatal neurological disorder that has limited interventional treatment, despite extensive research over the past several decades. A
Read moreTreatment involving a single injection has long-lasting effects
Read moreJoin world renowned cancer researchers as they gather to discuss latest advances in cancer cell and gene therapy for solid tumors
Read moreHertz Fellow David Schaffer uses high throughput genetic sequencing technology to identify gene variants that can potentially help restore sight, repair hearts damaged by Fabry disease, and improve lung function in patients with cystic fibrosis.
Read moreFor first time, fibroblast-derived model of early embryo will allow extensive study into causes of very early miscarrriage and effects of toxins and drugs on early development
Read moreAn international collaboration between Great Ormond Street Hospital, the UCL GOS Institute for Child Health and Harvard Medical School has
Read moreFindings may boost design of antiviral treatments, gene therapies and vaccines
Read moreThe CRISPR-based gene editor, C-to-G Base Editor (CGBE), opens up treatment avenues for up to 40 per cent of genetic disorders caused by single-nucleotide mutations
Read moreA gene therapy for chronic pain could offer a safer, non-addictive alternative to opioids. Researchers at the University of California San Diego developed the new therapy, which works by temporarily repressing a gene involved in sensing pain. It increased pain tolerance in mice, lowered their sensitivity to pain and provided months of pain relief without causing numbness.
Read moreEarly clinical trial shows experimental drug crosses blood-brain barrier to trigger death of brain tumor cells
Read moreUC researchers discover how two genes cooperate to cause cancer growth and can target treatments to stop it from happening
Read moreFindings explain how plants use RNA to defend against fungal invaders
Read morePICI awards nearly $3 million to six early career researchers
Read moreRecipient Mount Sinai approaching a potential breakthrough in the fight against solid tumors
Read moreThe in-person Cell Culture Engineering XVII Conference has been postponed until October 16 – October 22, 2021 in Tucson, Arizona.
Read moreLong thought a vestigial part of human cells, new genetic analysis of the primary cilium shows that it may be tied to common conditions like diabetes and kidney failure
Read moreResults of a world-first Canadian pilot study on patients treated with gene therapy for Fabry disease show that the treatment is working and safe.
Read moreFirst joint common mechanisms grants announced
Read moreWATERTOWN, Mass. – Gene therapy has traditionally been conceptualized as a one-time, curative treatment option; however, research shows that there
Read moreFour brief, illuminating talks by experts on gene therapy, optic nerve regeneration, the role of artificial intelligence, and the importance of trust between physician and patient.
Read moreCRISPR gene editing has transformed research, but it is not perfect, and can sometimes target unintended genes; to watch CRISPR enzymes respond to different genes, Leipzig University researchers developed a new method using DNA origami and were able to me
Read moreNew perspective on the role of sRNAs in the disease
Read more‘Exploring one of the biggest challenges facing genomics today – understanding genetic variants’
Read moreInhibiting a gene involved in the abnormal growth of blood vessels in certain ocular disorders may reduce retinal neovascularization, researchers report in The American Journal of Pathology
Read moreScientists have identified a way to “rescue” muscle cells that have genetically mutated, paving the way to a possible new
Read moreUC San Diego researchers have launched a first-in-human Phase I clinical trial to assess the safety and efficacy of a gene therapy to deliver a key protein into the brains of persons with Alzheimer’s disease or Mild Cognitive Impairment, a condition that often precedes full-blown dementia.
Read moreUC San Diego researchers will inject harmless virus carrying a restorative gene into participants’ brains, where earlier animal studies suggest it may slow, prevent or reverse progression of the neurological disorder
Read moreDiscovery signifies potential for revolutionary new genetic approach to treatment of kidney disease
Read moreMachine learning study initiated at the Wyss Institute in collaboration with Google Research enables unprecedented AAV capsid diversification with potential for improving gene therapies
Read moreMUSC Hollings Cancer Center researcher finds loss of STING in recipient dendritic cells increases GVHD severity
Read moreApproach rapidly generates the functional diversity needed to evade neutralization by the immune system, allowing more patients to benefit from gene therapies
Read morePROVIDENCE, R.I. [Brown University] — New research provides insights into the treatment of Christianson syndrome (CS), an X-linked genetic disease
Read moreA broadly applicable AAV genome-coupled immunomodulation strategy helps cloak the AAV virus from unwanted immune responses, and offers important insights into ocular inflammation
Read moreDivision of synthetic gene circuit workloads will make therapy more effective.
Read moreExceptional science, Enhanced digital experience, Flexible viewing hours
Read morePompe disease is a hereditary genetic disorder caused by a deficiency of acid alpha-glucosidase leading to build-up of glycogen in
Read moreAnnouncement of articles in the February issue of neurosurgical Focus.
Read moreNew preclinical study shows vector results in significantly more hemoglobin production than vectors currently used in gene therapy for sickle cell disease and beta-thalassemia
Read more